The SpineCor system is a flexible brace that is principally prescribed for Idiopathic Scoliosis patients with a Cobb angle between 15° and 50° and Risser sign 0 to 3.  The brace is fitted on the patient in accordance to a sub-classification of the traditional SRS definition of curve types.  The SpineCor Assistant Software guides the treatment provider through the fitting process.  The brace is prescribed to be worn by the patients 20 out of 24 hours per day until they have reached maturity, with radiological evaluations performed prior to and immediately following the fitting of the brace, and every 4 to 6 months afterwards.  To accommodate for growth and postural changes, corrective bands need to be adjusted frequently and require replacement each 6-12 months for optimum brace performance.  Major brace components can last from 1.5 – 2 years.  A patient manual is provided that guides the patient in properly wearing the brace, as well as maintenance.  The SpineCor brace must only be fitted by a SpineCor accredited practitioner who has been trained to perform the corrective movements required for the fitting of the brace and has also fitted a minimum number of patients under supervision.

 

INDICATIONS for SpineCor Bracing

The SpineCor System was designed, developed, and tested for the treatment of diagnosed & confirmed Idiopathic Scoliosis.

Indications:

  •     Boy or Girl from 5 years of age +.
  •     Initial Cobb angle equal or above 15°, proven progression of more than 5° in last 6 months or strong family history.
  •     Initial Cobb angle equal or below 50°.
  •     Risser 0, 1, 2, 3 or pre-menarchial.
  •     Curve Types: All classes including curves that are inverse to normal patterns (e.g. Left Thoracic, Right Lumbar)

PROGNOSIS

To really change the natural progression of idiopathic scoliosis, it is essential to reduce the curvature enough to eliminate the negative impact of abnormal biomechanics and growth.  Therefore, it is possible to achieve a complete or almost complete correction of moderate curves, if the treatment is started before the main growth spurt (before Risser 1 and menarche).  In curves over 30 degrees of Cobb angle, or when the treatment started during or after the main growth spurt, the goal of the treatment is a stabilization of the deformity.  The therapeutic success is possible in more than 80% of cases.  The reference reducibility calculated as early as at 3/4 months of treatment, is useful in defining the prognosis.  However, for individual prognoses, the impact of the severity of the bone deformation, pattern of the growth and compliance must be considered.